J. L. Levin

956 total citations
15 papers, 725 citations indexed

About

J. L. Levin is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, J. L. Levin has authored 15 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in J. L. Levin's work include Complement system in diseases (7 papers), Congenital Heart Disease Studies (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). J. L. Levin is often cited by papers focused on Complement system in diseases (7 papers), Congenital Heart Disease Studies (2 papers) and Blood Coagulation and Thrombosis Mechanisms (2 papers). J. L. Levin collaborates with scholars based in United States, United Kingdom and Canada. J. L. Levin's co-authors include Linda M. Chatters, Robert Taylor, B. Paul Morgan, Rhian Goodfellow, Anwen S. Williams, Bryan Williams, Brandon Williams, Ronald F. Dodson, R. Duane Davis and G. Alexander Patterson and has published in prestigious journals such as Journal of the American College of Cardiology, Journal of Applied Physiology and Environmental Health Perspectives.

In The Last Decade

J. L. Levin

15 papers receiving 694 citations

Peers

Countries citing papers authored by J. L. Levin

Since Specialization

Citations

This map shows the geographic impact of J. L. Levin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. L. Levin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. L. Levin more than expected).

Fields of papers citing papers by J. L. Levin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. L. Levin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. L. Levin. The network helps show where J. L. Levin may publish in the future.

Co-authorship network of co-authors of J. L. Levin

This figure shows the co-authorship network connecting the top 25 collaborators of J. L. Levin. A scholar is included among the top collaborators of J. L. Levin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. L. Levin. J. L. Levin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Religion in the Lives of African Americans: Social, Psychological, and Health Perspectives 2004 ·Robert Taylor, Linda M. Chatters, J. L. Levin	437
2	An unusual case of mixed-dust exposure involving a "noncommercial" asbestos. 2001 ·Environmental Health Perspectives ·Ronald F. Dodson, J. L. Levin	19
3	Soluble complement receptor one (sCR1) inhibits the development and progression of rat collagen-induced arthritis 2000 ·Clinical & Experimental Immunology ·Rhian Goodfellow, Anwen S. Williams, J. L. Levin, Brandon Williams, B. Paul Morgan	49
4	Complement Inhibition Attenuates Human Lung Transplant Reperfusion Injury 1999 ·CHEST Journal ·Martin R. Zamora, R. Duane Davis, Shaf Keshavjee, L L Schulman, J. L. Levin, Una Ryan, G. Alexander Patterson	59
5	Phase I safety trial of soluble complement receptor type I (TP 10) in acute myocardial infarction 1998 ·Journal of the American College of Cardiology ·Gilbert J. Perry, (unknown), (unknown), J. L. Levin	2
6	Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis 1997 ·Clinical & Experimental Immunology ·Rhian Goodfellow, Anwen S. Williams, J. L. Levin, Bryan Williams, B. Paul Morgan	33
7	Local therapy with soluble complement receptor 1 (sCR1) suppresses inflammation in rat mono-articular arthritis 1997 ·Clinical & Experimental Immunology ·Rhian Goodfellow, Anwen S. Williams, J. L. Levin, Bryan Williams, B. Paul Morgan	38
8	The Effect of Soluble Complement Receptor 1 (sCR1) and Human Thyroid Antibodies on the Course of Experimental Autoimmune Thyroiditis in Rats 1996 ·Autoimmunity ·R. A. Metcalfe, Richard S. McIntosh, B. Paul Morgan, J. L. Levin, Anthony P. Weetman	7
9	Continuous complement (C) inhibition using soluble C receptor type 1 (sCR1): effect on hyperacute rejection (HAR) of pig-to-primate cardiac xenografts. 1996 ·PubMed ·Scott K. Pruitt, R. R. Bollinger, Bradley H. Collins, Henry C. Marsh, J. L. Levin, (unknown), W. M. Baldwin, Fred Sanfilippo	7
10	Requalifying examination and employment in immigrant physicians as predictors of successful immigration to Israel. 1996 ·PubMed ·Daniel Moldavsky, J. L. Levin, Arnon Elizur	1
11	Pseudocoarctation of the aortic arch in a patient with turner's syndrome 1985 ·Clinical Cardiology ·Lloyd W. Klein, J. L. Levin, William Weintraub, Jai B. Agarwal, Richard H. Helfant, (unknown)	1
12	Pseudocoarctation of the aortic arch in a patient with turner's syndrome 1984 ·Clinical Cardiology ·Lloyd W. Klein, J. L. Levin, William Weintraub, Jai B. Agarwal, Richard H. Helfant	11
13	Analysis of airway responses to dihomo-gamma-linolenic acid in the cat. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·J. L. Levin, E. W. Spannhake, Albert L. Hyman, Philip J. Kadowitz	2
14	Reversal of 5HT-induced bronchoconstriction by PGI2: distribution of central and peripheral actions 1980 ·Journal of Applied Physiology ·E. W. Spannhake, J. L. Levin, (unknown), Carl A. Gruetter, Albert L. Hyman, Philip J. Kadowitz	11
15	Thrombopoietic activity of fractions of rabbit plasma: studies in rabbits and mice. 1974 ·PubMed ·(unknown), (unknown), J. L. Levin	48

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact